Utah Medical Products Inc (UTMD)
68.63
+0.71
(+1.05%)
USD |
NASDAQ |
May 06, 12:54
Utah Medical Products Enterprise Value: 149.91M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 149.91M |
| May 02, 2024 | 147.65M |
| May 01, 2024 | 149.73M |
| April 30, 2024 | 143.74M |
| April 29, 2024 | 144.10M |
| April 26, 2024 | 142.73M |
| April 25, 2024 | 144.06M |
| April 24, 2024 | 147.18M |
| April 23, 2024 | 148.62M |
| April 22, 2024 | 150.66M |
| April 19, 2024 | 152.28M |
| April 18, 2024 | 147.43M |
| April 17, 2024 | 148.83M |
| April 16, 2024 | 150.63M |
| April 15, 2024 | 151.42M |
| April 12, 2024 | 152.56M |
| April 11, 2024 | 157.95M |
| April 10, 2024 | 157.84M |
| April 09, 2024 | 160.93M |
| April 08, 2024 | 157.37M |
| April 05, 2024 | 154.00M |
| April 04, 2024 | 152.17M |
| April 03, 2024 | 152.53M |
| April 02, 2024 | 155.15M |
| April 01, 2024 | 159.99M |
| Date | Value |
|---|---|
| March 31, 2024 | 161.36M |
| March 28, 2024 | 162.35M |
| March 27, 2024 | 159.01M |
| March 26, 2024 | 151.69M |
| March 25, 2024 | 156.03M |
| March 22, 2024 | 154.77M |
| March 21, 2024 | 154.62M |
| March 20, 2024 | 160.29M |
| March 19, 2024 | 155.92M |
| March 18, 2024 | 155.02M |
| March 15, 2024 | 157.29M |
| March 14, 2024 | 158.59M |
| March 13, 2024 | 160.80M |
| March 12, 2024 | 165.17M |
| March 11, 2024 | 159.21M |
| March 08, 2024 | 157.44M |
| March 07, 2024 | 159.21M |
| March 06, 2024 | 157.44M |
| March 05, 2024 | 161.09M |
| March 04, 2024 | 164.55M |
| March 01, 2024 | 158.74M |
| February 29, 2024 | 161.89M |
| February 28, 2024 | 160.87M |
| February 27, 2024 | 161.67M |
| February 26, 2024 | 163.05M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
142.73M
Minimum
Apr 26 2024
390.98M
Maximum
Nov 22 2021
264.59M
Average
262.22M
Median
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 1.055B |
| Retractable Technologies Inc | -12.89M |
| Xtant Medical Holdings Inc | 126.76M |
| Asensus Surgical Inc | 44.48M |
| Catheter Precision Inc | 0.8601M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 3.956M |
| Revenue (Quarterly) | 11.34M |
| Total Expenses (Quarterly) | 8.389M |
| EPS Diluted (Quarterly) | 1.093 |
| Gross Profit Margin (Quarterly) | 59.66% |
| Profit Margin (Quarterly) | 34.89% |
| Earnings Yield | 6.56% |
| Operating Earnings Yield | 6.51% |
| Normalized Earnings Yield | 6.561 |